Andrew Saxon, MD
Personal Statement
My area of expertise is addiction psychiatry.
Department Affiliations
Centers/Programs
Training Programs
Scholarly Expertise
Teaching Philosophy
My training philosophy involves serving as a role model for my trainees as well as generally apply a supportive, Socratic method.
- NIDA Clinical Trials Network: Pacific Northwest Node
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Impact of medical and recreational marijuana laws on cannabis, opioids and psychiatric medications: national study of VA patients, 2000 – 2024
- Preventing addiction related suicide
- Evaluating the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) Program
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
(2024 Aug 1)
Drug Alcohol Depend 261(): 111350
Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA
(2024 Aug 1)
Drug Alcohol Depend 261(): 111350
Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA
Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era.
(2024 May 1)
JAMA Netw Open 7(5): e2411398
Saxon AJ
(2024 May 1)
JAMA Netw Open 7(5): e2411398
Saxon AJ
Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder.
(2024 Mar 19)
J Subst Use Addict Treat 164(): 209339
Kan E, Baldwin LM, Mooney LJ, Saxon AJ, Zhu Y, Hser YI
(2024 Mar 19)
J Subst Use Addict Treat 164(): 209339
Kan E, Baldwin LM, Mooney LJ, Saxon AJ, Zhu Y, Hser YI
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.
(2024 Feb 28)
Addict Sci Clin Pract 19(1): 14
Rush AJ, Gore-Langton RE, Bart G, Bradley KA, Campbell CI, McKay J, Oslin DW, Saxon AJ, Winhusen TJ, Wu LT, Moran LM, Tai B
(2024 Feb 28)
Addict Sci Clin Pract 19(1): 14
Rush AJ, Gore-Langton RE, Bart G, Bradley KA, Campbell CI, McKay J, Oslin DW, Saxon AJ, Winhusen TJ, Wu LT, Moran LM, Tai B
"The Only Reason I Am Willing to Do It at All": Evaluation of VA's SUpporting Primary care Providers in Opioid Risk reduction and Treatment (SUPPORT) Center.
(2024 May-Jun 01)
J Addict Med 18(3): 248-255
Williams EC, Frost MC, Danner AN, Lott AMK, Achtmeyer CE, Hood CL, Malte CA, Saxon AJ, Hawkins EJ
(2024 May-Jun 01)
J Addict Med 18(3): 248-255
Williams EC, Frost MC, Danner AN, Lott AMK, Achtmeyer CE, Hood CL, Malte CA, Saxon AJ, Hawkins EJ
Show complete publication list »
